血管内大B细胞淋巴瘤患者未被满足的需求：3例报告及文献复习

李娴; 罗茹; 徐佳鸣; 金雪立; 王炜琴; 肖希斌; 钱文斌

doi:10.1631/jzus.B2300941

Your Location：

Home >

Browse articles >

血管内大B细胞淋巴瘤患者未被满足的需求：3例报告及文献复习

Scan QR Code

文章被引用时，请邮件提醒。

Submit

Correspondence | Updated：2025-05-28

血管内大B细胞淋巴瘤患者未被满足的需求：3例报告及文献复习
Unmet needs of patients with intravascular large B-cell lymphoma: three case reports and a literature review
浙江大学学报（英文版）（B辑：生物医学和生物技术） 2025年26卷第5期页码：493-502
Affiliations：

1.Department of Hematology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China
2.Department of Pathology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China
3.Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China
Funds：
DOI：10.1631/jzus.B2300941
中图分类号：
CSTR：
收稿日期：2023-12-27，

修回日期：2024-06-15，

纸质出版日期：2025-05-28
Accepted：

李娴,罗茹,徐佳鸣等.血管内大B细胞淋巴瘤患者未被满足的需求：3例报告及文献复习[J].浙江大学学报（英文版）（B辑：生物医学和生物技术）,2025,26(05):493-502.

Xian LI, Ru LUO, Jiaming XU, et al. Unmet needs of patients with intravascular large B-cell lymphoma: three case reports and a literature review[J]. Journal of zhejiang university-science b (biomedicine & biotechnology), 2025, 26(5): 493-502.
李娴,罗茹,徐佳鸣等.血管内大B细胞淋巴瘤患者未被满足的需求：3例报告及文献复习[J].浙江大学学报（英文版）（B辑：生物医学和生物技术）,2025,26(05):493-502. DOI： 10.1631/jzus.B2300941.

Xian LI, Ru LUO, Jiaming XU, et al. Unmet needs of patients with intravascular large B-cell lymphoma: three case reports and a literature review[J]. Journal of zhejiang university-science b (biomedicine & biotechnology), 2025, 26(5): 493-502. DOI： 10.1631/jzus.B2300941.

摘要

血管内大B细胞淋巴瘤（IVLBCL）是一种具有高度侵袭性的恶性非霍奇金淋巴瘤，作为结外弥漫大B细胞淋巴瘤（DLBCL）的一种罕见亚型，其特征是小血管腔内的淋巴细胞增殖。IVLBCL早期诊断困难，预后极差。本文介绍了3例IVLBCL患者，分别描述了患者的临床特征和病理特征。所述患者均接受了免疫化疗联合大剂量甲氨蝶呤和布鲁顿酪氨酸激酶抑制剂的综合方案，但疗效有限，仅一名患者获得了良好和持久的反应。本研究回顾了相关文献并进行总结，以进一步识别IVLBCL早期诊断的临床病理特征，并基于分子遗传特征和临床亚型对IVLBCL进行了精确的预后分层，讨论了联合靶向免疫药物的治疗新策略。目前临床上IVLBCL患者的诊断及治疗需求远未被满足，因此我们需要开展更多研究，增加该疾病早期诊断和治疗的可能性，以提高患者生存率。

Abstract

关键词

Keywords

references

Alaggio R , Amador C , Anagnostopoulos I , et al. , 2022 . The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms . Leukemia , 36 ( 7 ): 1720 - 1748 . https://doi.org/10.1038/s41375-022-01620-2 https://doi.org/10.1038/s41375-022-01620-2

Brunet V , Marouan S , Routy JP , et al. , 2017 . Retrospective study of intravascular large B-cell lymphoma cases diagnosed in Quebec: a retrospective study of 29 case reports . Medicine (Baltimore) , 96 ( 5 ): e5985 . https://doi.org/10.1097/MD.0000000000005985 https://doi.org/10.1097/MD.0000000000005985

Chen JM , Luo B , Luo XX , et al. , 2021 . Clinical subtypes, diagnosis, treatment and prognosis of intravascular large B-cell lymphoma in China . Chin J Oncol Prev Treat , 13 ( 3 ): 288 - 29 (in Chinese) . https://doi.org/10.3969/j.issn.1674-5671.2021.03.12 https://doi.org/10.3969/j.issn.1674-5671.2021.03.12

D'Angelo CR , Ku K , Gulliver J , et al. , 2019 . Intravascular large B-cell lymphoma presenting with altered mental status: a case report . World J Clin Oncol , 10 ( 12 ): 402 - 408 . https://doi.org/10.5306/wjco.v10.i12.402 https://doi.org/10.5306/wjco.v10.i12.402

Davis JW , Auerbach A , Crothers BA , et al. , 2022 . Intravascular large B-cell lymphoma . Arch Pathol Lab Med , 146 ( 9 ): 1160 - 1167 . https://doi.org/10.5858/arpa.2021-0165-RA https://doi.org/10.5858/arpa.2021-0165-RA

Ferreri AJM , Campo E , Ambrosetti A , et al. , 2004a . Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma . Ann Oncol , 15 ( 8 ): 1215 - 1221 . https://doi.org/10.1093/annonc/mdh274 https://doi.org/10.1093/annonc/mdh274

Ferreri AJM , Campo E , Seymour JF , et al. , 2004b . Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’ . Br J Haematol , 127 ( 2 ): 173 - 183 . https://doi.org/10.1111/j.1365-2141.2004.05177.x https://doi.org/10.1111/j.1365-2141.2004.05177.x

Ferreri AJM , Dognini GP , Bairey O , et al. , 2008 . The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in ‘Western’ patients with intravascular large B-cell lymphoma . Br J Haematol , 143 ( 2 ): 253 - 257 . https://doi.org/10.1111/j.1365-2141.2008.07338.x https://doi.org/10.1111/j.1365-2141.2008.07338.x

Fromowitz FB , Viola MV , Chao S , et al. , 1987 . ras p21 expression in the progression of breast cancer . Hum Pathol , 18 ( 12 ): 1268 - 1275 . https://doi.org/10.1016/s0046-8177(87)80412-4 https://doi.org/10.1016/s0046-8177(87)80412-4

Fukami Y , Koike H , Iijima M , et al. , 2020 . Demyelinating neuropathy due to intravascular large B-cell lymphoma . Intern Med , 59 ( 3 ): 435 - 438 . https://doi.org/10.2169/internalmedicine.3228-19 https://doi.org/10.2169/internalmedicine.3228-19

Geer M , Roberts E , Shango M , et al. , 2019 . Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States . Br J Haematol , 186 ( 2 ): 255 - 262 . https://doi.org/10.1111/bjh.15923 https://doi.org/10.1111/bjh.15923

Gonzalez-Farre B , Ramis-Zaldivar JE , de Anta NC , et al. , 2023 . Intravascular large B-cell lymphoma genomic profile is characterized by alterations in genes regulating NF-κB and immune checkpoints . Am J Surg Pathol , 47 ( 2 ): 202 - 211 . https://doi.org/10.1097/PAS.0000000000001978 https://doi.org/10.1097/PAS.0000000000001978

Gupta GK , Jaffe ES , Pittaluga S , 2019 . A study of PD-L1 expression in intravascular large B cell lymphoma: correlation with clinical and pathological features . Histopathology , 75 ( 2 ): 282 - 286 . https://doi.org/10.1111/his.13870 https://doi.org/10.1111/his.13870

Kanda M , Suzumiya J , Ohshima K , et al. , 2001 . Analysis of the immunoglobulin heavy chain gene variable region of intravascular large B-cell lymphoma . Virchows Arch , 439 ( 4 ): 540 - 546 . https://doi.org/10.1007/s004280100398 https://doi.org/10.1007/s004280100398

Kato K , Mori T , Kim SW , et al. , 2019 . Outcome of patients receiving consolidative autologous peripheral blood stem cell transplantation in the frontline treatment of intravascular large B-cell lymphoma: Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation . Bone Marrow Transplant , 54 ( 9 ): 1515 - 1517 . https://doi.org/10.1038/s41409-019-0491-7 https://doi.org/10.1038/s41409-019-0491-7

Klairmont MM , Cheng JJ , Martin MG , et al. , 2018 . Recurrent cytogenetic abnormalities in intravascular large B-cell lymphoma . Am J Clin Pathol , 150 ( 1 ): 18 - 26 . https://doi.org/10.1093/ajcp/aqy023 https://doi.org/10.1093/ajcp/aqy023

Liu ZY , Zhang YL , Zhu YC , et al. , 2020 . Prognosis of intravascular large B cell lymphoma (IVLBCL): analysis of 182 patients from global case series . Cancer Manag Res , 12 : 10531 - 10540 . https://doi.org/10.2147/CMAR.S267825 https://doi.org/10.2147/CMAR.S267825

Luo CC , Yu TT , Young KH , et al. , 2022 . HDAC inhibitor chidamide synergizes with venetoclax to inhibit the growth of diffuse large B-cell lymphoma via down-regulation of MYC, BCL2, and TP53 expression . J Zhejiang Univ-Sci B (Biomed & Biotechnol) , 23 ( 8 ): 666 - 681 . https://doi.org/10.1631/jzus.B2200016 https://doi.org/10.1631/jzus.B2200016

Lymphoid Disease Group , Chinese Society of Hematology , Chinese Medical Association , et al. , 2023 . Chinese expert consensus on the diagnosis and management of intravascular large B cell lymphoma (2023) . Chin J Hematol , 44 ( 3 ): 177 - 181 (in Chinese) . https://doi.org/10.3760/cma.j.issn.0253-2727.2023.03.001 https://doi.org/10.3760/cma.j.issn.0253-2727.2023.03.001

Mahadevan D , Spier C , Della Croce K , et al. , 2005 . Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures . Mol Cancer Ther , 4 ( 12 ): 1867 - 1879 . https://doi.org/10.1158/1535-7163.MCT-05-0146 https://doi.org/10.1158/1535-7163.MCT-05-0146

Matsue K , Abe Y , Narita K , et al. , 2019 . Diagnosis of intravascular large B cell lymphoma: novel insights into clinicopathological features from 42 patients at a single institution over 20 years . Br J Haematol , 187 ( 3 ): 328 - 336 . https://doi.org/10.1111/bjh.16081 https://doi.org/10.1111/bjh.16081

Meissner J , Finel H , Dietrich S , et al. , 2017 . Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience . Bone Marrow Transplant , 52 ( 4 ): 650 - 652 . https://doi.org/10.1038/bmt.2016.339 https://doi.org/10.1038/bmt.2016.339

Muftah S , Xu ZD , el Gaddafi W , et al. , 2012 . Synchronous intravascular large B-cell lymphoma within meningioma . Neuropathology , 32 ( 1 ): 77 - 81 . https://doi.org/10.1111/j.1440-1789.2011.01223.x https://doi.org/10.1111/j.1440-1789.2011.01223.x

Murase T , Nakamura S , Kawauchi K , et al. , 2000 . An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome . Br J Haematol , 111 ( 3 ): 826 - 834 . https://doi.org/10.1111/j.1365-2141.2000.02426.x https://doi.org/10.1111/j.1365-2141.2000.02426.x

Murase T , Yamaguchi M , Suzuki R , et al. , 2007 . Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5 . Blood , 109 ( 2 ): 478 - 485 . https://doi.org/10.1182/blood-2006-01-021253 https://doi.org/10.1182/blood-2006-01-021253

Poletto S , Novo M , Paruzzo L , et al. , 2022 . Treatment strategies for patients with diffuse large B-cell lymphoma . Cancer Treat Rev , 110 : 102443 . https://doi.org/10.1016/j.ctrv.2022.102443 https://doi.org/10.1016/j.ctrv.2022.102443

Ponzoni M , Ferreri AJM , Campo E , et al. , 2007 . Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting . J Clin Oncol , 25 ( 21 ): 3168 - 3173 . https://doi.org/10.1200/JCO.2006.08.2313 https://doi.org/10.1200/JCO.2006.08.2313

Ponzoni M , Campo E , Nakamura S , 2018 . Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks . Blood , 132 ( 15 ): 1561 - 1567 . https://doi.org/10.1182/blood-2017-04-737445 https://doi.org/10.1182/blood-2017-04-737445

Qiu LQ , Wang SA , Vega F , et al. , 2022 . From the archives of MD Anderson Cancer Center: intravascular large B-cell lymphoma with numerous circulating lymphoma cells . Ann Diagn Pathol , 58 : 151934 . https://doi.org/10.1016/j.anndiagpath.2022.151934 https://doi.org/10.1016/j.anndiagpath.2022.151934

Rajyaguru DJ , Bhaskar C , Borgert AJ , et al. , 2017 . Intravascular large B-cell lymphoma in the United States (US): a population-based study using surveillance, epidemiology, and end results program and national cancer database . Leuk Lymphoma , 58 ( 9 ): 2080 - 2088 . https://doi.org/10.1080/10428194.2017.1287363 https://doi.org/10.1080/10428194.2017.1287363

Sakakibara A , Inagaki Y , Imaoka E , et al. , 2018 . Autopsy case report of intravascular large B-cell lymphoma with neoplastic PD-L1 expression . J Clin Exp Hematop , 58 ( 1 ): 32 - 35 . https://doi.org/10.3960/jslrt.17037 https://doi.org/10.3960/jslrt.17037

Satoh T , Arai E , Kayano H , et al. , 2019 . Pulmonary intravascular large B-cell lymphoma accompanying synchronous primary pulmonary adenocarcinoma and benign interstitial lesions . J Clin Exp Hematop , 59 ( 3 ): 140 - 144 . https://doi.org/10.3960/jslrt.19012 https://doi.org/10.3960/jslrt.19012

Schmitz R , Wright GW , Huang DW , et al. , 2018 . Genetics and pathogenesis of diffuse large B-Cell lymphoma . N Engl J Med , 378 ( 15 ): 1396 - 1407 . https://doi.org/10.1056/NEJMoa1801445 https://doi.org/10.1056/NEJMoa1801445

Shimada K , Matsue K , Yamamoto K , et al. , 2008 . Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan . J Clin Oncol , 26 ( 19 ): 3189 - 3195 . https://doi.org/10.1200/JCO.2007.15.4278 https://doi.org/10.1200/JCO.2007.15.4278

Shimada K , Murase T , Matsue K , et al. , 2010 . Central nervous system involvement in intravascular large B-cell lymphoma: a retrospective analysis of 109 patients . Cancer Sci , 101 ( 6 ): 1480 - 1486 . https://doi.org/10.1111/j.1349-7006.2010.01555.x https://doi.org/10.1111/j.1349-7006.2010.01555.x

Shimada K , Yamaguchi M , Atsuta Y , et al. , 2020 . Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial . Lancet Oncol , 21 ( 4 ): 593 - 602 . https://doi.org/10.1016/S1470-2045(20)30059-0 https://doi.org/10.1016/S1470-2045(20)30059-0

Shimada K , Yoshida K , Suzuki Y , et al. , 2021 . Frequent genetic alterations in immune checkpoint‒related genes in intravascular large B-cell lymphoma . Blood , 137 ( 11 ): 1491 - 1502 . https://doi.org/10.1182/blood.2020007245 https://doi.org/10.1182/blood.2020007245

Takahashi H , Nishimaki H , Nakanishi Y , et al. , 2022 . Clinical impact of central nervous system-directed therapies on intravascular large B-cell lymphoma: a single institution’s experience . EJHaem , 3 ( 2 ): 467 - 470 . https://doi.org/10.1002/jha2.380 https://doi.org/10.1002/jha2.380

Turner JJ , Morton LM , Linet MS , et al. , 2010 . InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions . Blood , 116 ( 20 ): e90 - e98 . https://doi.org/10.1182/blood-2010-06-289561 https://doi.org/10.1182/blood-2010-06-289561

Vásquez J , Romero V , Vilas P , et al. , 2019 . Progressive edemas and generalized telangiectasia: a presentation of intravascular B-cell lymphoma . Clin Case Rep , 7 ( 12 ): 2429 - 2432 . https://doi.org/10.1002/ccr3.2514 https://doi.org/10.1002/ccr3.2514

Vieites B , Fraga M , López-Presas E , et al. , 2005 . Detection of t(14;18) translocation in a case of intravascular large B-cell lymphoma: a germinal centre cell origin in a subset of these lymphomas? Histopathology , 46 ( 4 ): 466 - 468 . https://doi.org/10.1111/j.1365-2559.2005.02013.x https://doi.org/10.1111/j.1365-2559.2005.02013.x

Xu-Monette ZY , Tu MF , Jabbar KJ , et al. , 2015 . Clinical and biological significance of de novo CD5 + diffuse large B-cell lymphoma in Western countries . Oncotarget , 6 ( 8 ): 5615 - 5633 . https://doi.org/10.18632/oncotarget.3479 https://doi.org/10.18632/oncotarget.3479

Yegappan S , Coupland R , Arber DA , et al. , 2001 . Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma . Mod Pathol , 14 ( 11 ): 1147 - 1156 . https://doi.org/10.1038/modpathol.3880450 https://doi.org/10.1038/modpathol.3880450

Yuan YY , Wang EH , Wang L , 2022 . The first case of a collision tumor of gastrointestinal stromal tumor and intravascular large B cell lymphoma . Ann Hematol , 101 ( 1 ): 233 - 235 . https://doi.org/10.1007/s00277-021-04418-x https://doi.org/10.1007/s00277-021-04418-x

Zhang F , Luo XL , Chen Y , et al. , 2015 . Intravascular large B-cell lymphoma involving gastrointestinal stromal tumor: a case report and literature review . Diagn Pathol , 10 : 214 . https://doi.org/10.1186/s13000-015-0446-2 https://doi.org/10.1186/s13000-015-0446-2

Zhang Y , Chen C , Zhao DQ , et al. , 2023 . P1185: a prospective single-center phase 2 study of zanubrutinib plus R-CHOP in treat-naïve intravascular large B cell lymphoma . HemaSphere, 7(Sl) : e 1662573 . https://doi.org/10.1097/01.HS9.0000971636.16625.73 https://doi.org/10.1097/01.HS9.0000971636.16625.73

浏览量

Downloads

CSCD

工具集

关联资源

暂无数据